Status:

COMPLETED

Improving Sleep Quality in Heart Failure

Lead Sponsor:

Johns Hopkins University

Conditions:

Sleep Disturbance

Heart Failure

Eligibility:

All Genders

21-79 years

Phase:

PHASE4

Brief Summary

Poor sleep quality is common in patients with heart failure. The limited available evidence intimates that improving sleep quality in patients with heart failure may improve morbidity and quality of l...

Eligibility Criteria

Inclusion

  • Age 21-79 years old
  • HFrEF, EF ≤ 45% (by echocardiography)
  • NYHA functional class I to III
  • Able to give written consent
  • On goal-directed medical therapy for HF, with stable dosing of HF medications for 2 weeks prior to enrollment
  • No hospitalizations for HF within the past month
  • Positive response to experiencing any of the following sleep-related symptoms at least once a week:
  • Difficulty falling asleep
  • Waking up during the night and having difficulty getting back to sleep
  • Waking up too early in the morning and being unable to get back to sleep.

Exclusion

  • Use of sedative-hypnotics, anxiolytic, or benzodiazepines within the previous 2 weeks
  • Current treatment with other sedating medications such as opioids
  • On therapy for pharmacological therapy for depression
  • History of alcohol/drug dependence
  • History of liver disease, HIV, or severe COPD
  • On Thorazine
  • Current use of ketoconazole
  • Current use of tricyclic antidepressants
  • Current use of macrolide antibiotics
  • Current use of anticonvulsant medications
  • Pregnancy. A urine pregnancy test will be performed to exclude pregnancy in potential subjects.

Key Trial Info

Start Date :

November 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 25 2019

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT03307005

Start Date

November 1 2017

End Date

January 25 2019

Last Update

February 11 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Johns Hopkins Bayview Campus, Asthma and Allergy Center

Baltimore, Maryland, United States, 21224